Article
Serine Proteases Profiles of Leishmania (Viannia) Braziliensis Clinical Isolates With Distinct Susceptibilities to Antimony
2021-01-20
Abstract excerpt
<title>Abstract</title> <p>Glucantime® (Sb<sup>V</sup>) is the first-line treatment against leishmaniasis in South America. Its effectiveness has been associated with modulation of the parasite detoxification system that, in turn, is related to serine proteases such as subtilisins. In this study, 12 <italic>Leishmania (Viannia) braziliensis</italic> isolates from patients that presented clinical cure (Responders...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8fc2509-d628-5ee4-967d-1573c211e8fd
- DOI
- 10.21203/rs.3.rs-79982/v2
